SOURCE: Astro-Med, Inc.

Astro-Med, Inc.

January 07, 2013 10:00 ET

Astro-Med Schedules Conference Call to Discuss Divestiture of Grass Technologies

WEST WARWICK, RI--(Marketwire - Jan 7, 2013) -  Rhode Island-based electronics manufacturer Astro-Med, Inc. (NASDAQ: ALOT) issued a joint press release earlier today with Natus Medical Incorporated (NASDAQ: BABY) announcing that Astro-Med has entered into a definitive agreement to sell its Grass Technologies business segment.

Investor Conference Call

In conjunction with this release, Astro-Med will host a conference call on Tuesday, January 8th, 2013 at 11 AM EST. Those wishing to participate in the call should dial 1-877-941-0844, and enter meeting ID 4588513. It will also be webcast on the Investing Portion of our website.

The Astro-Med, Inc. webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (, a password-protected event management site.

Following the live event, a webcast of the recorded call will be available for ten days at A telephone replay of the conference call will also be available for seven days by dialing 1-800-406-7325 with passcode 4588513.

About Astro-Med, Inc.

Astro-Med, Inc. is a leading manufacturer of specialty high tech printing systems, electronic medical instrumentation, and test and measurement data acquisition systems. Astro-Med, Inc. products are sold under the brand names Astro-Med® and QuickLabel® Systems, and are employed around the world in a wide range of aerospace, medical, military, industrial, labeling and packaging applications. Astro-Med, Inc. is a member of the Russell Microcap® Index. Additional information is available by visiting

Safe Harbor Statement

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2012 annual report and its annual and quarterly filings with the Securities and Exchange Commission.

Contact Information